@paradigmmedcom

1415-1 Initiating an IVT Anti-VEGF for DR/DME - DME

Accredited Activity A1403-2 – AAO Eye Connect RVO

Transforming AML Care: Expert Approaches to IDH- and FLT3-Mutant Management

Accredited Activity A1403-1 – AAO Eye Connect RVO

“Delivering” on the Promise of Sustained Treatment: Innovations in Long-Term Disease Control

Applying New Guidelines and New Treatments for Patients With Lupus Nephritis

Discovering New Targets and Unique Strategies to Treat Sjögren’s Disease

Driving Toward Better Schizophrenia Care: Finding Another Route in a Complex Disease With Long-Acting Injectable Medications

The Many Faces of Neovascular Retinal Disease: Individualizing the Use of Sustained Delivery Therapy

“Fact Vs Fiction”: Dispelling Myths and Misinformation on the Use of Biostimulatory Fillers in Regenerative Aesthetics

Improving Outcomes for Patients With Tenosynovial Giant Cell Tumor

Modern Treatment of Neovascular Retinal Diseases: Minimizing Injection Burden, Optimizing Outcomes

Diverse Applications of Sustained Delivery Therapy in Retinal Vascular Diseases

Clinical Mastery of Facial Rejuvenation in Ethnic Patient Populations: Achieving Aesthetic Balance through Individualized Treatment

Common Practice Dilemmas in the Age of Second-Generation Therapy A Retina Unplugged Podcast Activity

Managing Diabetic Eye Disease in the Real World: New Solutions, Fewer Injections

What’s New in Food Allergy: Important Questions Asked and Answered

Pathways to Care: Updates on CSU

Pathology Perspectives on HER2-Low and -Ultralow Expression Levels in Breast Cancer

Moving Forward With Sustained Treatment of Retinal Diseases: An Update

Fresh Perspectives on Pulmonary Arterial Hypertension: A Patient-Centered Approach to Care

Innovations in the Tailored Management of Cellulite: Precision-Guided Treatment of Cellulite for Optimal Long-Term Patient Outcomes

Roundtable: ADCs Targeting HER2 in NSCLC

Harnessing the Power of Second-Generation Therapy to Address Clinical Biomarkers of Neovascular Retinal Disease

A New Dawn in the Treatment of Lupus Nephritis

Advanced Uses of Long-Lasting Biostimulatory Dermal Fillers for Novel Application on the Face and Body

Molluscum Contagiosum: To Treat or Not to Treat New and Emerging Treatment Strategies

Second-Generation Therapy for Retinal Vascular Diseases: More Than Meets the Eye

Personalizing Treatment for nAMD Using New Anti-VEGF Therapies

Maximizing Individualized Treatment Strategies for Age-Related Macular Degeneration

Multidisciplinary Strategies to Ensure Equity Across the Continuum of Diabetic Eye Care

HER2 Overexpression/Mutation as an Actionable Target in NSCLC

Point-Counterpoint: Deep Dive into CLL/SLL: Management of Newly Diagnosed and Refractory Disease

Special Delivery: Novel and Emerging Devices and Therapies That Allow for Sustained Treatment of Retinal Diseases

Navigating Treatment Selection in CLL/SLL: Approaches for Initial and Refractory Cases

New and Emerging Therapies Preserving Renal Function in Lupus Nephritis

Accredited Activity 1345-1 - nAMD

Accredited Activity 1345-2 - nAMD

Accredited Activity 1345-3 - nAMD

Accredited Activity 1345-4 - nAMD

Accredited Activity 1345-5 - nAMD